Advances in liposome research in the field of antitumor
Liposomes, as biocompatible and safe nanocarriers with easily modified surfaces, can be well used in the field of antitumor. Their targeting properties have contributed to the reduction of drug dosage and non-target cell toxicity. To further exploit the targeting properties of liposomes, passive tar...
Main Author: | Xu Xiaochuang |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2023-01-01
|
Series: | BIO Web of Conferences |
Subjects: | |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2023/06/bioconf_fbse2023_01013.pdf |
Similar Items
-
Photodynamic therapy – hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
by: Nikola Plenagl, et al.
Published: (2019-01-01) -
PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study
by: Shirleide Santos Nunes, et al.
Published: (2022-01-01) -
In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole
by: Aline Teixeira Maciel e Silva, et al.
Published: (2023-12-01) -
Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer
by: Chen Y, et al.
Published: (2020-07-01) -
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
by: Jiani Yuan, et al.
Published: (2019-07-01)